Clinical studies recruiting near Hattiesburg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0088 · Celgene · NCT05519085 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Hattiesburg Clinic Hematology/Oncology · Amgen · NCT07005128 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Hattiesburg Clinic /ID# 248033 · AbbVie · NCT04928846 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site US047 · Incyte Corporation · NCT07522073 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Hattiesburg Clinic Hematology/Oncology · Bristol-Myers Squibb · NCT06561386 Caris Biorepository Research Protocol
Phase N/A · Hattiesburg Clinic · Caris Science, Inc. · NCT01499394 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · Massive Bio SYNERGY-AI site · Massive Bio, Inc. · NCT03452774 A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Met
Phase 1/Phase 2 · Hattiesburg Clinic · Janssen Research & Development, LLC · NCT05379595 A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R)
Phase 3 · Hattiesburg Clinic Hematology/Oncology ( Site 5416) · Merck Sharp & Dohme LLC · NCT05947851 Hybrid HIIT-FES Cycling Program on Individuals With Spinal Cord Injury to Improve Health
NA · William Carey University · William Carey University · NCT07648173 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · Hattiesburg Clinic · Bristol-Myers Squibb · NCT07011745 Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in A
Phase 2 · Hattiesburg Clinic /ID# 233443 · AbbVie · NCT04895436 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET
Phase 3 · Private Practice - Dr. Ronald Louis Schwartz · Bristol-Myers Squibb · NCT06976203 A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-108
Phase 3 · Hattiesburg Clinic ( Site 0064) · Merck Sharp & Dohme LLC · NCT06997497 A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Phase 3 · Local Institution - 2629 · Bristol-Myers Squibb · NCT06937229 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Hattiesburg Clinic - Hematology/Oncology Clinic · National Cancer Institute (NCI) · NCT04267848 A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Len
Phase 3 · Hattiesburg Clinic · Regeneron Pharmaceuticals · NCT06149286 Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemi
Phase N/A · Hattiesburg Hematology and Oncology Clinic · BeiGene · NCT05640102 A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet
Phase 2 · Local Institution - 0180 · Bristol-Myers Squibb · NCT07680764 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Southern Surgery Center · Stryker Instruments · NCT03072927 Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch
Phase 3 · AbbVie · NCT05125302 A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Di
Phase 3 · Hattiesburg Clinic · Regeneron Pharmaceuticals · NCT06091254 A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Parti
Phase 3 · Hattiesburg Clinic · Janssen Research & Development, LLC · NCT06662786 A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in
Phase 3 · Hattiesburg Clinic Hematology/Oncology ( Site 0104) · Merck Sharp & Dohme LLC · NCT06841354 Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Phase N/A · Medtronic · NCT00271180 A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib
Phase 3 · Hattiesburg Hematology and Oncology Clinic · BeOne Medicines · NCT06742996 Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initi
NA · Hattiesburg Clinic · Timothy Mullett · NCT07682597 Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small C
Phase 3 · Hattiesburg Clinic Hematology/Oncology ( Site 0104) · Merck Sharp & Dohme LLC · NCT06170788 A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combinat
Phase 3 · Research Site · AstraZeneca · NCT06103864

Look up another city

Look up another condition